임상교실 - 교수진 소개

임형준 교수

임형준 교수

임형준 / Hyung-Joon Yim

  • 소속내과학교실
  • 직위교수
  • 세부전공소화기내과
  • 연구실위치
  • 구내전화번호
  • 팩스
  • 이메일gudwns21@korea.ac.kr
학력사항
198803~199402 고려대학교 의학과 의학사
199609~199808 고려대학교 대학원 의학과 의학석사
200209~200502 고려대학교 대학원 의학과 의학박사
교육 및 경력사항
199403~199502 고려대학교 의료원 안암병원 수련의
199503~199902 고려대학교 의료원 구로병원 내과 전공의
200205~200302 고려대학교 의료원 안산병원 임상강사
200303~200402 고려대학교 의료원 구로병원 임상강사
200403~200502 고려대학교 의료원 안산병원 임상조교수
200503~200602 University of Michigan Research Fellow
200603~200802 고려대학교 의료원 안산병원 조교수
200803~201302 고려대학교 의료원 안산병원 부교수
201203 고려대학교 의료원 안산병원 소화기내과장
201303 고려대학교 의료원 안산병원 교수
학술활동
199902 대한내과학회 정회원
200309 대한 소화기 내시경학회 정회원
200309 대한간학회 정회원
200409 대한 소화기 학회 정회원
200603~200911 대한 간학회 보험 위원
200806~201106 대한 간암 연구학회 학술 위원
200911 대한 간학회 학술 위원
201107~201307 대한 간암 연구학회 학술위원장
대표논문
  • Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005/200602

  • Clinical outcomes of chronic hepatitis B patients with persistently detectable serum hepatitis B virus DNA during lamivudine therapy/200708

  • Factors related to post-treatment relapse in chronic hepatitis B patients who lost HBeAg after lamivudine therapy/200512

  • Durability of Antiviral Response in HBeAg-Positive Chronic Hepatitis B Patients Who Maintained Virologic Response for One Year After Lamivudine Discontinuation/200810

  • Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study/200808

  • Problems faced by Korean patients with chronic liver disease and the role of the Korean Association for the Study of the Liver--emphases on social discrimination, insufficiency of reimbursement coverage, and deficiency of the welfare system/200806

  • Analysis of the factors that affect the mortality rate in severe acute pancreatitis/200801

  • Evolution of multi-drug resistant hepatitis B virus during sequential therapy/200609

  • A genotype-independent real-time PCR assay for quantification of hepatitis B virus DNA/200702

  • Is cytokeratin immunoreactivity useful in the diagnosis of short-segment Barretts oesophagus in Korea?/200506

  • Chronic cirrhotic hepatitis B patients with a high incidence of hepatic decompensation after viral breakthrough with lamivudine-resistant mutants and during rescue treatment/200807

  • Management of antiviral-resistant chronic hepatitis B virus infection/200806

  • Efficacy of Helicobacter pylori eradication therapy in chronic liver disease/200804

  • Genetic analysis of HAV strains isolated from patients with acute hepatitis in Korea, 2005-2006/200805

  • Changes in liver stiffness after acute or chronic liver injury due to viral hepatitis--does fibrosis exist after recovery from acute viral hepatitis?/200909

  • Korean Liver Cancer Study Group. A comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinoma/201012

  • Treatment of lamivudine-resistant chronic hepatitis B infection: a multicenter retrospective study/201302

  • Korean Liver Cancer Study Group. A randomized comparative study of high-dose and low-dose hepatic arterial infusion chemotherapy for intractable, advanced hepatocellular carcinoma/201001

  • Serum alanine aminotransferase level alone may not accurately represent necro-inflammation in patients with acute hepatitis/200903

  • Serum aminotransferase levels instead of etiology affects the accuracy of transient elastography in chronic viral hepatitis patients/201103

  • Clinical characteristics of chronic pancreatitis according to the history of pancreatitis/200904

  • Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B/201001

  • Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis/201204

  • Clinical features of acute hepatitis A in recent two years/200811

  • Is colonoscopic screening necessary for patients with gastric adenoma or cancer?/201311

  • A case of advanced hepatocellular carcinoma with portal vein tumor invasion controlled by percutaneous ethanol injection therapy/200903

  • Clinical courses after administration of oral corticosteroids in patients with severely cholestatic acute hepatitis A; three cases/201009

  • Computed tomography findings for predicting severe acute hepatitis with prolonged cholestasis/201304

  • Durability of antiviral response in HBeAg-positive chronic hepatitis B patients who maintained virologic response for one year after lamivudine discontinuation/200907

  • Clinical features and prognosis of spontaneous bacterial peritonitis in korean patients with liver cirrhosis: a multicenter retrospective study/200909

  • Application of the HALF index obviates the need for liver biopsy in half of all patients with chronic hepatitis B/201106

  • Healthy range for serum ALT and the clinical significance of ""unhealthy"" normal ALT levels in the Korean population/201102

  • Effectiveness and safety of repeated quadruple therapy in Helicobacter pylori infection after failure of second-line quadruple therapy: repeated quadruple therapy as a third-line therapy/201110

  • Endoscopic treatment of duodenal bleeding caused by direct hepatocellular carcinoma invasion with an ethanol injection/201201

  • A novel estimation of the relative economic value in terms of different chronic hepatitis B treatment options/201301

  • Systemic Cytotoxic Chemotherapy of Patients With Advanced Hepatocellular Carcinoma in the Era of Sorafenib Nonavailability/201309

  • Prognosis of hepatitis B-related liver cirrhosis in the era of oral nucleos(t)ide analog antiviral agents/201210

  • Comparison of the methods for tumor response assessment in patients with hepatocellular carcinoma undergoing transarterial chemoembolization/201306

  • Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade/201309

  • Significance of anti-HCV signal-to-cutoff ratio in predicting hepatitis C viremia/200912

  • Validation of a Mayo post-operative mortality risk prediction model in Korean cirrhotic patients/201102

  • Pulmonary Arteriovenous Malformation in Cryptogenic Liver Cirrhosis Associated with Turner's Syndrome/201006

  • Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels/200911

  • Dynamic changes in liver stiffness during the course of acute hepatitis A/201004

  • Levels of hepatitis B virus (HBV) replication during the nonreplicative phase: HBV quantification by real-time PCR in Korea/200709

  • Hepatitis B virus genetic diversity and mutant/200812

  • HBsAg seroclearance in chronic hepatitis B: implications for hepatocellular carcinoma/201101

  • Comparison of clevudine and entecavir for treatment-naive patients with chronic hepatitis B virus infection: two-year follow-up data/201112

  • Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis/201211

  • Terlipressin-induced hyponatremic seizure/201004

  • APPROACH Working Group. Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions/201002

  • Current status of liver diseases in Korea: hepatitis B/200912

  • Focal hepatic steatosis that appears as a liver mass in imaging/201105

  • Duodenobronchial fistula presenting with persistent pneumonia: report of a case/201109

  • Endovascular management for isolated spontaneous dissection of the superior mesenteric artery: report of two cases and literature review/201108

  • Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus/201109

  • Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients/201112

  • Comparative study of Helicobacter pylori eradication rates with 5-day quadruple ""concomitant"" therapy and 7-day standard triple therapy/201301

  • Low vitamin d status is associated with nonalcoholic Fatty liver disease independent of visceral obesity in Korean adults/201310

  • Clinical features and prognosis of spontaneous bacterial peritonitis in korean patients with liver cirrhosis: a multicenter retrospective study/200909

  • Effectiveness of three times daily lansoprazole/amoxicillin dual therapy for Helicobacter pylori infection in Korea/201201

  • Recurrence rates and factors for recurrence after radiofrequency ablation combined with transarterial chemoembolization for hepatocellular carcinoma: a retrospective cohort study/201107

  • Current status of molecular targeted therapies in hepatocellular carcinoma/201303

  • Multicenter comparison of PEG-IFN α2a or α2b plus ribavirin for treatment-naïve HCV patient in Korean population/201304

  • Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization/200901

  • Hepatitis B viral surface mutations in patients with adefovir resistant chronic hepatitis B with A181T/V polymerase mutations/201002

  • Treatment strategies using adefovir dipivoxil for individuals with lamivudine-resistant chronic hepatitis B/201212

  • Genotypic shift of the hepatitis A virus and its clinical impact on acute hepatitis A in Korea: a nationwide multicenter study/201311

  • Laparoscopic resection of HCC implanted in the peritoneal cavity: a case detected by PET after hepatic resection/200810

  • Two cases of toxic hepatitis caused by arrowroot juice/200912

  • Liver cirrhosis induced by porphyria cutanea tarda: a case report and review/201012

  • The efficacy of early scheduled follow-up endoscopic retrograde cholangiopancreatography after common bile duct stone removal/201103

  • Serum cystatin C level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels/201106

  • A case of systemic amyloidosis with pancreatic involvement mimicking autoimmune pancreatitis/200812

  • Rifampin-induced Pseudomembranous Colitis with Rectosigmoid Sparing/201112

  • Small bowel carcinoma in young patient detected by double-balloon enteroscopy/201110

  • The HBV DNA cutoff value for discriminating patients with HBeAgnegative chronic hepatitis B from inactive carriers/201105

  • Efficacy and tolerability of peginterferon alpha plus ribavirin in the routine daily treatment of chronic hepatitis C patients in Korea: a multi-center, retrospective observational study/201201

  • Adding adefovir vs. switching to entecavir for lamivudine-resistant chronic hepatitis B (ACE study): a 2-year follow-up randomized controlled trial/201302

  • A nationwide seroepidemiology of hepatitis C virus infection in South Korea/201304

  • Small bowel pseudomelanosis associated with oral iron therapy/201307

  • Role of Hepatitis B Surface Antigen (HBsAg) in Identifying True Inactive HBsAg Carriers Infected With Genotype C Hepatitis B Virus/201309

  • Abdominal obesity as a risk factor for the development of erosive esophagitis in subjects with a normal esophago-gastric junction/200912

  • Clinical significance of the detection of antinuclear antibodies in patients with acute hepatitis a/201109

  • Optimal time for repeating the IgM anti-hepatitis A virus antibody test in acute hepatitis A patients with a negative initial test/201203
  • 목록